Improving B-ALL Outcomes in Children With Down Syndrome
LEUKEMIA Improving B-ALL Outcomes in Children With Down Syndrome Tori Rodriguez, MA, LPC, AHC|January 5, 2024 Child patient with Down
January 5, 2024
LEUKEMIA Improving B-ALL Outcomes in Children With Down Syndrome Tori Rodriguez, MA, LPC, AHC|January 5, 2024 Child patient with Down
Key Points How the body manages (regulates) body temperature is different in people with Down syndrome compared to people without
Periodontal diseases (PDs) have been documented to be significantly more prevalent and severe in patients with Down syndrome (DS). Different
Psoriasis and psoriatic arthritis can present simultaneously or separately in children and may pose a diagnostic challenge. The objective of
This graphic discusses the different types of decision-making supports available.Source: The Arc
This video discusses the repurposing existing drugs and therapies for new uses. Source: Massachusetts Down Syndrome Congress
Growing evidence has suggested that Type I Interferon (I-IFN) plays a potential role in the pathogenesis of Down Syndrome (DS).Source:
Thyroid dysfunction stands as the most prevalent endocrine disorder in individuals with Down syndrome, particularly showcasing both clinical and subclinical
This article gives an overview of Down syndrome for professionals.Source: Merck
Individuals with Down syndrome are among those most at risk of disparities, and Black individuals with Down syndrome might be